These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15781212)

  • 1. An association between a NQO1 genetic polymorphism and risk of lung cancer.
    Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
    Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
    Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
    Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An association between NQO1 genetic polymorphism and risk of bladder cancer.
    Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
    Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
    Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
    Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
    Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
    Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
    Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
    Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
    Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
    Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
    Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the NAD(P)H:quinone oxidoreductase (NQO1) 609C->T polymorphism with lung cancer risk among male smokers.
    Lawson KA; Woodson K; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2275-6. PubMed ID: 16172245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
    Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
    Malik MA; Zargar SA; Mittal B
    DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.